HM
ALXN
HealthCor Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-61,330
| Closed | -$9.58M | – | 105 |
|
|
2020
Q4 | $9.58M | Buy |
+61,330
| New | +$9.58M | 0.37% | 39 |
|
|
2020
Q3 | – | Sell |
-666,510
| Closed | -$74.8M | – | 62 |
|
|
2020
Q2 | $74.8M | Buy |
666,510
+518,240
| +350% | +$58.2M | 3.13% | 12 |
|
|
2020
Q1 | $13.3M | Buy |
+148,270
| New | +$13.3M | 0.57% | 40 |
|
|
2018
Q3 | – | Sell |
-486,300
| Closed | -$60.4M | – | 57 |
|
|
2018
Q2 | $60.4M | Buy |
+486,300
| New | +$60.4M | 1.92% | 19 |
|
|
2017
Q2 | – | Sell |
-950,000
| Closed | -$115M | – | 46 |
|
|
2017
Q1 | $115M | Buy |
950,000
+688,860
| +264% | +$83.5M | 5.28% | 6 |
|
|
2016
Q4 | $32M | Sell |
261,140
-388,860
| -60% | -$47.6M | 1.81% | 20 |
|
|
2016
Q3 | $79.7M | Buy |
+650,000
| New | +$79.7M | 4.85% | 6 |
|
|
2016
Q2 | – | Sell |
-142,920
| Closed | -$19.9M | – | 49 |
|
|
2016
Q1 | $19.9M | Buy |
142,920
+83,030
| +139% | +$11.6M | 1.13% | 27 |
|
|
2015
Q4 | $11.4M | Sell |
59,890
-390,110
| -87% | -$74.4M | 0.69% | 29 |
|
|
2015
Q3 | $70.4M | Buy |
+450,000
| New | +$70.4M | 3.96% | 11 |
|
|
2015
Q1 | – | Sell |
-127,100
| Closed | -$23.5M | – | 72 |
|
|
2014
Q4 | $23.5M | Sell |
127,100
-22,900
| -15% | -$4.24M | 1.31% | 25 |
|
|
2014
Q3 | $24.9M | Sell |
150,000
-325,000
| -68% | -$53.9M | 1.28% | 23 |
|
|
2014
Q2 | $74.2M | Buy |
475,000
+457,700
| +2,646% | +$71.5M | 3.72% | 8 |
|
|
2014
Q1 | $2.63M | Sell |
17,300
-432,700
| -96% | -$65.8M | 0.16% | 44 |
|
|
2013
Q4 | $59.8M | Buy |
450,000
+50,000
| +13% | +$6.64M | 3.63% | 9 |
|
|
2013
Q3 | $46.5M | Sell |
400,000
-250,000
| -38% | -$29M | 2.49% | 13 |
|
|
2013
Q2 | $60M | Buy |
+650,000
| New | +$60M | 3.63% | 9 |
|